Lipoprotein apheresis and proprotein convertase subtilisin/kexin type 9 inhibitors: Do we have a vanquishing new strategy?

Veljić, Ivana (57203875022)Ivana (57203875022)VeljićPolovina, Marija (35273422300)Marija (35273422300)PolovinaMilinković, Ivan (51764040100)Ivan (51764040100)MilinkovićSeferović, Petar M (6603594879)Petar M (6603594879)Seferović2025-06-122025-06-122019https://doi.org/10.1177/2047487318817671https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060160273&doi=10.1177%2f2047487318817671&partnerID=40&md5=1a30e535f38844be3773e6b0aea53826https://remedy.med.bg.ac.rs/handle/123456789/5591[No abstract available]Lipoprotein apheresis and proprotein convertase subtilisin/kexin type 9 inhibitors: Do we have a vanquishing new strategy?